Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1
Cytarabine and UCN-01 in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1
EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Sodium Salicylate in Treating Patients With Advanced Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment
- Status
- TERMINATED
- Phase
- PHASE1
Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Antithymocyte Globulin and Cyclosporine in Treating Patients With Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE3
Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Hematologic Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder
- Status
- TERMINATED
- Phase
- PHASE1
Chemotherapy in Treating Patients Who Have Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
6-Hydroxymethylacylfulvene in Treating Patients With Refractory Myelodysplastic Syndrome, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Blastic Phase Chronic Myelogenous Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Monoclonal Antibody Therapy in Treating Patients With Primary Myelodysplastic Syndrome
- Status
- WITHDRAWN
- Phase
- PHASE2
Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Vaccine Therapy in Treating Patients With Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1